Clinical Trial Update: The Aging Brain and Cognition: Contribution of Vascular Injury, Amyloid Plaque and Tau Protein to Cognitive Dysfunction After Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating how vascular injury, amyloid plaques, and tau contribute to cognitive dysfunction after stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Dementia
• Vascular Mild Cognitive Impairment

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Post-stroke Dementia, Vascular Mild Cognitive Impairment | Phase 2 | Status: COMPLETED